Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Autism Spectrum Disorder (ASD) Clinical Trials

A listing of Autism Spectrum Disorder (ASD) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (234) clinical trials

The Children’s Research Unit at Albert Einstein College of Medicine in the Bronx, New York is currently recruiting participants in the area for a genetic study of African Americans with autism. We are looking for children of all ages who identify as African American and have a diagnosis or are ...

Phase N/A

The purpose of the study is to assess the efficacy of two highly requested treatments for children with autism spectrum disorder, both of which are directed at increasing functional skills and reducing maladaptive sensory behaviors: occupational therapy using sensory strategies for decreasing sensory dysfunction and applied behavioral analytic (ABA) therapy.

Phase N/A

Purpose of the study: The Children’s Research Unit at Albert Einstein College of Medicine of Yeshiva University are currently recruiting participants for a research study that examines whether multisensory integration (the brain’s processing of information from different senses) is impaired in people with autism. Protocol summary: Information from the various ...

Phase N/A

This is a Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics of RO5285119 in children and adolescents aged 5-17 years with ASD who are high functioning (intelligence quotient [IQ] greater than or equal to [≥] 70). Enrollment will be staggered, ...

Phase N/A

People with autism spectrum disorder are asked to participate in a research study being conducted by Montefiore Medical Center.

This is a Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics of RO5285119 in children and adolescents aged 5-17 years with ASD who are high functioning (intelligence quotient [IQ] greater than or equal to [>=] 70). Enrollment will be staggered, ...

Phase

A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension.  This study will evaluate the efficacy, safety, and pharmacokinetics of 10 mg of oral administration balovaptan once a day (QD) compared with matching placebo in adults (18 years and older) with autism spectrum disorder (ASD). ...

Phase

The study will look at the effect of balovaptan on social behavior and communication in people with autism spectrum disorder (ASD). It is a 24-week double-blind study followed by a two-year open-label extension.  

Phase